SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-24-000004
Filing Date
2024-02-13
Accepted
2024-02-13 07:07:23
Documents
16
Period of Report
2024-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biib-20240213.htm   iXBRL 8-K 23965
2 EX-99.1 exhibit991-q42023pressrele.htm EX-99.1 587532
6 newbiogenlogo.jpg GRAPHIC 2811
  Complete submission text file 0000875045-24-000004.txt   782312

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20240213.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20240213_lab.xml EX-101.LAB 24139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20240213_pre.xml EX-101.PRE 12526
17 EXTRACTED XBRL INSTANCE DOCUMENT biib-20240213_htm.xml XML 2692
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 24622571
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)